MedTrace Logo

Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts

NCT06309420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2024-03-13

No results posted yet for this study

Summary

The present study was set-up to evaluate clinical efficacy of Pixie CO2 versus a comparator product (Wortie®) for the treatment of common and plantar warts.

Conditions

  • Warts

Interventions

DEVICE

Cryogenic treatment of warts (Pixie CO2)

Treatment of common and plantar warts by cryotherapy treatment.

DEVICE

Cryogenic treatment of warts (Wortie®)

Treatment of common and plantar warts by cryotherapy treatment.

Sponsors & Collaborators

  • Oystershell NV

    lead INDUSTRY

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-07
Primary Completion
2020-08-10
Completion
2020-08-10

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309420 on ClinicalTrials.gov